CMPS Stock Summary and Trading Ideas (Compass Pathways PLC - American Depository Shares | NASDAQ:CMPS)

Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.

Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.

As of June 11, 2026, CMPS stock price climbed to $11.41 with 3,577,393 million shares trading.

CMPS has a beta of 1.35, meaning it tends to be more sensitive to market movements. CMPS has a correlation of 0.03 to the broad based SPY ETF.

CMPS has a market cap of $1.54 billion. This is considered a Small Cap stock.

In the last 3 years, CMPS traded as high as $14.76 and as low as $2.25.

The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, GWX, BBC.

CMPS has outperformed the market in the last year with a return of +139.7%, while the SPY ETF gained +23.6%. In the last 3 month period, CMPS beat the market returning +53.4%, while SPY returned +9.2%. However, in the most recent 2 weeks CMPS has underperformed the stock market by returning -3.7%, while SPY returned -1.7%.

CMPS support price is $10.40 and resistance is $11.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.